Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden · Delayed Price · Currency is SEK 13.72
+0.02 (0.15%)
Aug 13, 2026, 5:29 PM CET
Xspray Pharma AB Market Cap
Xspray Pharma AB has a market cap or net worth of 649.61 million as of August 13, 2026. Its market cap has decreased by -65.97% in one year.
Market Cap
649.61M
Enterprise Value
617.00M
Revenue
2.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.72
ChartMarket Cap Chart
Since September 28, 2017, Xspray Pharma AB's market cap has increased from 375.71M to 649.61M, an increase of 72.90%. That is a compound annual growth rate of 6.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 649.61M | -50.52% |
| Dec 30, 2025 | 1.31B | -14.72% |
| Dec 30, 2024 | 1.54B | 23.14% |
| Dec 29, 2023 | 1.25B | -3.30% |
| Dec 30, 2022 | 1.29B | -2.48% |
| Dec 30, 2021 | 1.33B | -63.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Sep 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medivir AB | 1.11B |
| SynAct Pharma AB | 1.05B |
| AlzeCure Pharma AB | 926.67M |
| Infant Bacterial Therapeutics AB | 875.64M |
| Oncopeptides AB | 628.51M |
| FluoGuide | 510.10M |
| Corline Biomedical AB | 466.48M |
| Cantargia AB | 454.96M |